PortfoliosLab logoPortfoliosLab logo
COSM vs. AYTU
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

COSM vs. AYTU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cosmos Health Inc. (COSM) and Aytu BioPharma, Inc. (AYTU). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, COSM achieves a -47.59% return, which is significantly lower than AYTU's -19.23% return.


COSM

1D
3.33%
1M
-31.24%
YTD
-47.59%
6M
-52.58%
1Y
-43.14%
3Y*
-57.75%
5Y*
-70.07%
10Y*
-33.14%

AYTU

1D
-2.33%
1M
-19.54%
YTD
-19.23%
6M
2.44%
1Y
17.98%
3Y*
4.89%
5Y*
-54.20%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

COSM vs. AYTU - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
COSM
Cosmos Health Inc.
-47.59%-25.56%-52.55%-69.08%-94.59%-33.92%131.82%-45.00%-60.78%1,086.05%
AYTU
Aytu BioPharma, Inc.
-19.23%52.94%-40.14%-24.87%-86.00%-77.42%-38.35%22.41%-98.22%-88.85%

Correlation

The correlation between COSM and AYTU is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.12

Correlation (All Time)
Calculated using the full available price history since Feb 2, 2017

0.09

Fundamentals

EPS

COSM:

-$0.62

AYTU:

-$2.91

PS Ratio

COSM:

0.13

AYTU:

0.43

Total Revenue (TTM)

COSM:

$59.79M

AYTU:

$56.60M

Gross Profit (TTM)

COSM:

$6.82M

AYTU:

$36.14M

EBITDA (TTM)

COSM:

-$14.92M

AYTU:

-$27.34M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

COSM vs. AYTU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

COSM
COSM Risk / Return Rank: 2424
Overall Rank
COSM Sharpe Ratio Rank: 2222
Sharpe Ratio Rank
COSM Sortino Ratio Rank: 2626
Sortino Ratio Rank
COSM Omega Ratio Rank: 2727
Omega Ratio Rank
COSM Calmar Ratio Rank: 2222
Calmar Ratio Rank
COSM Martin Ratio Rank: 2525
Martin Ratio Rank

AYTU
AYTU Risk / Return Rank: 5252
Overall Rank
AYTU Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
AYTU Sortino Ratio Rank: 5151
Sortino Ratio Rank
AYTU Omega Ratio Rank: 5151
Omega Ratio Rank
AYTU Calmar Ratio Rank: 5252
Calmar Ratio Rank
AYTU Martin Ratio Rank: 5353
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

COSM vs. AYTU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cosmos Health Inc. (COSM) and Aytu BioPharma, Inc. (AYTU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


COSMAYTUDifference

Sharpe ratio

Return per unit of total volatility

-0.44

0.27

-0.71

Sortino ratio

Return per unit of downside risk

-0.14

0.92

-1.06

Omega ratio

Gain probability vs. loss probability

0.98

1.12

-0.13

Calmar ratio

Return relative to maximum drawdown

-0.51

0.51

-1.02

Martin ratio

Return relative to average drawdown

-0.80

1.23

-2.03

COSM vs. AYTU - Sharpe Ratio Comparison

The current COSM Sharpe Ratio is -0.44, which is lower than the AYTU Sharpe Ratio of 0.27. The chart below compares the historical Sharpe Ratios of COSM and AYTU, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


COSMAYTUDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.44

0.27

-0.71

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.45

-0.64

+0.19

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.09

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.05

-0.36

+0.31

Drawdowns

COSM vs. AYTU - Drawdown Comparison

The maximum COSM drawdown since its inception was -99.92%, roughly equal to the maximum AYTU drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for COSM and AYTU.


Loading charts...

Drawdown Indicators


COSMAYTUDifference

Max Drawdown

Largest peak-to-trough decline

-99.92%

-100.00%

+0.08%

Max Drawdown (1Y)

Largest decline over 1 year

-80.24%

-35.47%

-44.77%

Max Drawdown (3Y)

Largest decline over 3 years

-93.53%

-70.24%

-23.29%

Max Drawdown (5Y)

Largest decline over 5 years

-99.87%

-99.12%

-0.75%

Max Drawdown (10Y)

Largest decline over 10 years

-99.92%

Current Drawdown

Current decline from peak

-99.92%

-100.00%

+0.08%

Average Drawdown

Average peak-to-trough decline

-64.42%

-95.14%

+30.72%

Ulcer Index

Depth and duration of drawdowns from previous peaks

51.40%

14.66%

+36.74%

Volatility

COSM vs. AYTU - Volatility Comparison

Cosmos Health Inc. (COSM) has a higher volatility of 16.79% compared to Aytu BioPharma, Inc. (AYTU) at 12.52%. This indicates that COSM's price experiences larger fluctuations and is considered to be riskier than AYTU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


COSMAYTUDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.79%

12.52%

+4.27%

Volatility (6M)

Calculated over the trailing 6-month period

57.97%

33.97%

+24.00%

Volatility (1Y)

Calculated over the trailing 1-year period

99.06%

66.08%

+32.98%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

157.81%

85.63%

+72.18%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

373.25%

188.35%

+184.90%

Dividends

COSM vs. AYTU - Dividend Comparison

Neither COSM nor AYTU has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

COSM vs. AYTU - Financials Comparison

This section allows you to compare key financial metrics between Cosmos Health Inc. and Aytu BioPharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


10.00M15.00M20.00M25.00M30.00M20222023202420252026
17.11M
12.41M
(COSM) Total Revenue
(AYTU) Total Revenue
Values in USD except per share items

Frequently Asked Questions


COSM and AYTU have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

COSM has higher volatility (16.79%) compared to AYTU (12.52%). In terms of maximum drawdown, COSM dropped -99.92% vs AYTU's -100.00%.

AYTU currently has the higher Sharpe Ratio (0.27 vs -0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for COSM and AYTU

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer